Pfizer is facing a US lawsuit alleging wrongful termination and retaliation against a whistleblower after the company’s former director of Global Compliance Analytics discovered what he viewed to be potential violations in China of the US Foreign Corrupt Practices Act.
US Secretary of Commerce Gina Raimondo has made the first official visit to China by a US commerce official in three years, paving the way to possible improvements in bilateral relations. Despite ongoing geopolitical tensions as a major concern for US firms in China, some are returning to growth in the country.
In this latest Chinese-language podcast: China's latest crackdown on health sector non-compliance will have long-lasting effects on the sector; Chinese PD-1 inhibitor developers heading to the US.
As Beijing gets tougher in an all-out campaign to root out corruption and non-compliance in the pharma sector, more physician conferences are jeopardized and an increasing number of hospital presidents are placed under investigation. Meanwhile, one industry association issues new guidance for members.
Read Full Story: https://news.google.com/rss/articles/CBMicmh0dHBzOi8vc2NyaXAucGhhcm1haW50ZWxs...
Pulsar Helium (LSE:PLSR) has issued a statement dismissing market rumours after becoming aware that a third-party broker had circulated misleading communications describing a supposed private plac...